InsidersTradesSigma
Follow the Eikon Therapeutics, Inc. stock price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). The latest transaction was filed on 10 February 2026 (C). Among the most active insiders: PERLMUTTER ROGER M. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
Eikon Therapeutics, Inc. is a company focused on developing innovative therapies based on genome editing technology. It is listed on NASDAQ under the ticker symbol EIKN.